M-Pap

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the reduction of fever and the temporary relief of minor aches and pains associated with various conditions. These conditions include headache, muscular aches, backache, arthritis, the common cold, toothache, and menstrual cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 3 teaspoonfuls (15 mL) every 5 hours. The maximum allowable dosage should not exceed 15 teaspoonfuls (75 mL) within a 24-hour period.

For children under 12 years of age, administration should occur only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist. It is essential to follow the specific recommendations provided by the healthcare provider regarding the appropriate dosage and frequency for this age group.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

This product is contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Additionally, the product should not be used for pain relief for more than 10 days or for fever for more than 3 days unless directed by a healthcare provider.

Warnings and Precautions

This product contains acetaminophen, which carries significant risks that healthcare professionals must communicate to patients.

Liver Warning Severe liver damage may occur if the maximum daily dosage of 8 teaspoonfuls (40 mL) is exceeded within a 24-hour period. Additionally, the risk of liver damage increases if acetaminophen is taken concurrently with other medications containing acetaminophen or if the patient consumes three or more alcoholic drinks daily while using this product.

Allergy Alert Acetaminophen may lead to severe skin reactions. Symptoms indicative of such reactions include skin reddening, blisters, and rash. In the event of a skin reaction, patients should discontinue use immediately and seek medical assistance.

Sore Throat Warning Patients experiencing a severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, should consult a healthcare provider promptly.

General Precautions Healthcare professionals should advise patients to consult a doctor prior to use if they have any health issues, particularly liver disease. Additionally, patients should be encouraged to discuss any other medications they are taking, including blood thinners such as warfarin, with their doctor or pharmacist before using this product.

Emergency Medical Help In cases of overdose, immediate medical attention is essential. Patients should be instructed to contact a Poison Control Center or seek emergency medical help right away, even if no signs or symptoms are apparent.

When to Stop Taking the Product Patients should be advised to discontinue use and contact their healthcare provider if they experience new symptoms such as rash, hives, itching, or hoarseness; if redness or swelling occurs; if pain worsens or persists for more than ten days; if fever worsens or lasts for more than three days; or if symptoms do not improve. These may be indicative of a serious condition requiring medical evaluation.

Side Effects

Severe liver damage may occur in patients who exceed the maximum daily dosage of 8 teaspoonfuls (40 mL) within a 24-hour period, particularly when combined with other medications containing acetaminophen or when consuming three or more alcoholic drinks daily while using this product.

Patients should be aware of the potential for severe skin reactions associated with acetaminophen, which may manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Additionally, if patients experience a sore throat that is severe, persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, they should consult a healthcare professional promptly.

Patients are advised to stop use and contact a doctor if new symptoms arise, such as rash, hives, itching, or hoarseness; if redness or swelling occurs; if pain worsens or lasts longer than ten days; if fever intensifies or persists beyond three days; or if symptoms do not improve, as these may indicate a serious condition.

Before using this product, patients with pre-existing health issues, particularly liver disease, should consult a healthcare provider. Furthermore, it is recommended that patients discuss the use of this product with a doctor or pharmacist if they are taking other medications, including blood thinners such as warfarin.

An overdose of acetaminophen can lead to liver damage. In cases of overdose, it is crucial to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is essential even if no signs or symptoms are initially apparent.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of M-Pap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should use this medication only under the direct guidance of a licensed healthcare professional, including a doctor or pharmacist.

For adolescents aged 12 years and older, the recommended dosage is 3 teaspoonfuls (15 mL) every 5 hours, with a maximum limit of 15 teaspoonfuls (75 mL) within a 24-hour period.

Geriatric Use

Elderly patients may have unique health considerations that warrant careful evaluation prior to the use of this medication. While no specific geriatric use information is provided in the prescribing insert, it is advisable for healthcare providers to inquire about any existing health issues, particularly liver disease, which is more prevalent among geriatric patients.

Given the absence of recommended age considerations, dosage adjustments, or special precautions explicitly mentioned for elderly patients, clinicians should exercise caution and closely monitor this population for any adverse effects or complications that may arise during treatment. It is essential to assess the overall health status and comorbidities of elderly patients to ensure safe and effective use of the medication.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should be aware that this product contains acetaminophen, which carries a risk of severe liver damage. It is crucial for these patients to adhere strictly to the recommended dosage guidelines. The maximum daily amount should not exceed 8 teaspoonfuls (40 mL) within a 24-hour period. Additionally, patients must avoid the concurrent use of other medications containing acetaminophen, as this can further increase the risk of liver damage.

Patients with compromised liver function should also be cautious regarding alcohol consumption. The intake of three or more alcoholic drinks per day while using this product is not recommended, as it may exacerbate the risk of liver injury.

Before using this product, patients with any health issues, particularly those related to liver disease, should consult a healthcare professional. It is essential to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, as prompt medical attention is critical, even if no signs or symptoms are present.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of symptoms may not be immediately apparent, making it essential to act swiftly.

It is imperative that individuals who suspect an overdose seek medical assistance or contact a Poison Control Center without delay. Prompt medical attention is crucial, even in the absence of noticeable signs or symptoms, as early intervention can mitigate potential complications associated with liver damage.

Healthcare providers should ensure that patients and caregivers are informed about the importance of immediate action in the case of an overdose, emphasizing that timely medical evaluation can be life-saving.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Serious side effects associated with the use of this product may be reported through the designated contact number. Reports received voluntarily or through surveillance programs contribute to the ongoing assessment of the product's safety profile.

Patient Counseling

Healthcare providers should advise patients about the importance of adhering to the recommended dosage of this medication, as taking more than the recommended dose may lead to liver damage. In the event of an overdose, patients should seek medical help or contact a Poison Control Center immediately, as prompt medical attention is critical even if no signs or symptoms are present.

Patients should be informed not to use this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist for clarification.

It is essential to communicate that this medication should not be used for more than 10 days for pain or more than 3 days for fever unless directed by a healthcare provider. Patients should also be cautioned against using this medication if they have a known allergy to acetaminophen or any of the inactive ingredients in the product.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience new symptoms such as rash, hives, itching, or hoarseness. Additionally, patients should be advised to stop use and seek medical advice if they notice redness or swelling, if their pain worsens or persists beyond 10 days, if their fever worsens or lasts more than 3 days, or if their symptoms do not improve, as these may indicate a serious condition.

While using this product, patients must be reminded not to exceed the recommended dose. It is also advisable for patients to consult a doctor before use if they have any health issues, particularly liver disease. Furthermore, patients should be encouraged to speak with a doctor or pharmacist before using this medication if they are taking other drugs, including blood thinners such as warfarin.

Storage and Handling

Dispensed product should be provided in a tight, light-resistant container equipped with a child-resistant cap.

Storage conditions require maintaining a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F and 86°F). Proper adherence to these storage guidelines is essential to ensure the integrity and efficacy of the product.

Additional Clinical Information

Patients aged 12 years and older are advised to take 3 teaspoonfuls (15 mL) every 5 hours, with a maximum of 15 teaspoonfuls (75 mL) in a 24-hour period. For children under 12 years of age, administration should occur only under the direct guidance of a licensed professional, doctor, or pharmacist.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, it is important to keep the product out of reach of children. Serious side effects associated with the use of this product can be reported through the designated postmarketing experience contact number.

Drug Information (PDF)

This file contains official product information for M-Pap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)